Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $8.24M | $1.65M | +399.45% |
Operating Income | $-127.71M | $-138.89M | +8.05% |
Net Income | $-53.23M | $-67.61M | +21.26% |
EPS (Basic) | $-1.54 | $-1.58 | +2.53% |
EPS (Diluted) | $-1.54 | $-1.58 | +2.53% |
R&D Expense | $42.77M | $103M | -58.47% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $210.58M | $384.8M | -45.28% |
Current Assets | $182.8M | $286.35M | -36.16% |
Total Liabilities | $191.39M | $152.79M | +25.26% |
Current Liabilities | $65.94M | $74.31M | -11.26% |
Stockholders' Equity | $19.19M | $232.01M | -91.73% |
Cash & Equivalents | $138.54M | $64.44M | +114.99% |
Long-Term Debt | $51.67M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-98.01M | $-106.93M | +8.34% |
Investing Cash Flow | $99.04M | $47.21M | +109.78% |
Financing Cash Flow | $5.97M | $514,000 | +1062.45% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1550.6% | -8422.9% | +6872.27% |
Net Margin | -646.4% | — | — |
ROE | -277.4% | — | — |
ROA | -25.3% | — | — |
Current Ratio | $2.772 | — | — |
Debt to Equity | $9.974 | — | — |
Other companies in Biotechnology